Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells.

Pogue SL, Preston BT, Stalder J, Bebbington CR, Cardarelli PM.

J Interferon Cytokine Res. 2004 Feb;24(2):131-9.

PMID:
14980077
2.

IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.

Mohty M, Vialle-Castellano A, Nunes JA, Isnardon D, Olive D, Gaugler B.

J Immunol. 2003 Oct 1;171(7):3385-93.

3.

Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.

Santodonato L, D'Agostino G, Nisini R, Mariotti S, Monque DM, Spada M, Lattanzi L, Perrone MP, Andreotti M, Belardelli F, Ferrantini M.

J Immunol. 2003 May 15;170(10):5195-202.

4.

[In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia].

Wu CY, Zhang LS, Zhang YF, Chai Y, Yi LC, Song FX.

Ai Zheng. 2005 Apr;24(4):425-31. Chinese.

PMID:
15820064
6.

Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells.

Carbonneil C, Aouba A, Burgard M, Cardinaud S, Rouzioux C, Langlade-Demoyen P, Weiss L.

AIDS. 2003 Aug 15;17(12):1731-40.

PMID:
12891059
7.
8.

Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12.

Zou W, Borvak J, Marches F, Wei S, Galanaud P, Emilie D, Curiel TJ.

J Immunol. 2000 Oct 15;165(8):4388-96.

9.

Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes.

Conti L, Cardone M, Varano B, Puddu P, Belardelli F, Gessani S.

Eur J Immunol. 2008 Mar;38(3):750-62. doi: 10.1002/eji.200737395.

10.

CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells.

Krug A, Rothenfusser S, Selinger S, Bock C, Kerkmann M, Battiany J, Sarris A, Giese T, Speiser D, Endres S, Hartmann G.

J Immunol. 2003 Apr 1;170(7):3468-77.

11.

IL-4 alone without the involvement of GM-CSF transforms human peripheral blood monocytes to a CD1a(dim), CD83(+) myeloid dendritic cell subset.

Roy KC, Bandyopadhyay G, Rakshit S, Ray M, Bandyopadhyay S.

J Cell Sci. 2004 Jul 15;117(Pt 16):3435-45. Epub 2004 Jun 22.

12.

Interferon-alpha and viral triggers promote functional maturation of human monocyte-derived dendritic cells.

Farkas A, Tonel G, Nestle FO.

Br J Dermatol. 2008 May;158(5):921-9. doi: 10.1111/j.1365-2133.2008.08508.x. Epub 2008 Mar 25.

13.

Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-alpha.

Della Bella S, Nicola S, Riva A, Biasin M, Clerici M, Villa ML.

J Leukoc Biol. 2004 Jan;75(1):106-16. Epub 2003 Oct 2.

PMID:
14525963
14.

Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.

Nieda M, Terunuma H, Eiraku Y, Deng X, Nicol AJ.

Exp Dermatol. 2015 Jan;24(1):35-41. doi: 10.1111/exd.12581. Epub 2014 Dec 8.

PMID:
25363560
15.

Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.

Vuckovic S, Fearnley DB, Mannering SI, Dekker J, Whyte LF, Hart DN.

Exp Hematol. 1998 Dec;26(13):1255-64.

PMID:
9845382
16.

Cholera toxin impairs the differentiation of monocytes into dendritic cells, inducing professional antigen-presenting myeloid cells.

Veglia F, Sciaraffia E, Riccomi A, Pinto D, Negri DR, De Magistris MT, Vendetti S.

Infect Immun. 2011 Mar;79(3):1300-10. doi: 10.1128/IAI.01181-10. Epub 2010 Dec 13.

17.

Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.

Tosi D, Valenti R, Cova A, Sovena G, Huber V, Pilla L, Arienti F, Belardelli F, Parmiani G, Rivoltini L.

J Immunol. 2004 May 1;172(9):5363-70.

18.

Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.

Tso CL, Zisman A, Pantuck A, Calilliw R, Hernandez JM, Paik S, Nguyen D, Gitlitz B, Shintaku PI, de Kernion J, Figlin R, Belldegrun A.

Cancer Res. 2001 Nov 1;61(21):7925-33.

19.

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

Santini SM, Lapenta C, Logozzi M, Parlato S, Spada M, Di Pucchio T, Belardelli F.

J Exp Med. 2000 May 15;191(10):1777-88.

Supplemental Content

Support Center